| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Bronx VA Medical Center |
| Information provided by: | Bronx VA Medical Center |
| ClinicalTrials.gov Identifier: | NCT00255554 |
Purpose
Subjects will receive six months of DBT, consisting of one 90-minute group and one 60-minute individual session per week as well as telephone availability of the individual therapist. Half the subjects will concurrently receive escitalopram while half will receive placebo, in a randomized double-blind design.
| Condition | Intervention |
|
Borderline Personality Disorder |
Behavioral: Dialectical Behavioral Therapy Drug: Escitalopram |
| MedlinePlus related topics: | Personality Disorders |
| Drug Information available for: | Escitalopram Benzetimide Citalopram Citalopram hydrobromide Dexetimide Escitalopram oxalate |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment |
| Official Title: | Effects of Dialectical Behavioral Therapy and Escitalopram on Impulsive Aggression, Affective Instability and Cognitive Processing in Borderline Personality Disorder |
Eligibility
| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria: Is a male or female between 18 and 60 who meets criteria for Borderline Personality Disorder and has been off psychotropic medications for at least 2 weeks (6 weeks for fluoxetine).
-
Exclusion Criteria: Meets criteria for Schizophrenia, Bipolar Disorder, Mental Retardation, current or recent Substance Dependence or a current Major Depressive Episode. Subjects also should not currently be in individual psychotherapy. (Case management and work therapy programs are allowed.)
-
Contacts and Locations| Contact: Emily Hart | 212-241-0441 | mpgroup@mssm.edu |
| United States, New York | |||||
| Bronx VA Medical Center | Recruiting | ||||
| Bronx, New York, United States, 10029 | |||||
| Bronx VA Medical Center |
| Principal Investigator: | Marianne Goodman, MD | Bronx VA Medical Center/Mount Sinai School of Medicine |
More Information
| Study ID Numbers: | 3277-03-0027 |
| First Received: | November 17, 2005 |
| Last Updated: | November 17, 2005 |
| ClinicalTrials.gov Identifier: | NCT00255554 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
|
|
